Difficulty: Medium
Average Score: 93%
Practice
FDA-approved in November 2019, voxelotor is used to treat which of these conditions?
Correct answer
B
Rationale
Voxelotor (Choice B), approved in 2019, treats sickle cell disease by increasing hemoglobin oxygen affinity, making it correct. It's not for hemolytic anemia (Choice A) broadly, lymphoma (Choice C), or polycythemia (Choice D), confirming B.